JPWO2020024002A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020024002A5 JPWO2020024002A5 JP2021529491A JP2021529491A JPWO2020024002A5 JP WO2020024002 A5 JPWO2020024002 A5 JP WO2020024002A5 JP 2021529491 A JP2021529491 A JP 2021529491A JP 2021529491 A JP2021529491 A JP 2021529491A JP WO2020024002 A5 JPWO2020024002 A5 JP WO2020024002A5
- Authority
- JP
- Japan
- Prior art keywords
- tent
- peg
- pegylated
- composition
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023196375A JP7786745B2 (ja) | 2018-07-31 | 2023-11-20 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
| JP2025203043A JP2026026159A (ja) | 2018-07-31 | 2025-11-25 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2018902779 | 2018-07-31 | ||
| AU2018902779A AU2018902779A0 (en) | 2018-07-31 | Composition and method | |
| PCT/AU2019/050793 WO2020024002A1 (en) | 2018-07-31 | 2019-07-30 | Pegylated tetanus neurotoxins and treatment of hypotonia |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023196375A Division JP7786745B2 (ja) | 2018-07-31 | 2023-11-20 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021533201A JP2021533201A (ja) | 2021-12-02 |
| JP2021533201A5 JP2021533201A5 (https=) | 2022-08-05 |
| JPWO2020024002A5 true JPWO2020024002A5 (https=) | 2022-08-05 |
Family
ID=69230503
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021529491A Pending JP2021533201A (ja) | 2018-07-31 | 2019-07-30 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
| JP2023196375A Active JP7786745B2 (ja) | 2018-07-31 | 2023-11-20 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
| JP2025203043A Pending JP2026026159A (ja) | 2018-07-31 | 2025-11-25 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023196375A Active JP7786745B2 (ja) | 2018-07-31 | 2023-11-20 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
| JP2025203043A Pending JP2026026159A (ja) | 2018-07-31 | 2025-11-25 | Ｐｅｇ化破傷風神経毒素および筋緊張低下の治療 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20210353724A1 (https=) |
| EP (2) | EP4134133A1 (https=) |
| JP (3) | JP2021533201A (https=) |
| KR (1) | KR20210040407A (https=) |
| CN (2) | CN120661638A (https=) |
| AU (1) | AU2019315327B2 (https=) |
| BR (1) | BR112021001520A2 (https=) |
| CA (2) | CA3167665A1 (https=) |
| MX (1) | MX2021001181A (https=) |
| NZ (1) | NZ772266A (https=) |
| SG (1) | SG11202100646SA (https=) |
| WO (1) | WO2020024002A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240268895A1 (en) | 2023-02-15 | 2024-08-15 | Canon Medical Systems Corporation | X-ray diagnostic apparatus, x-ray diagnostic system, and x-ray diagnostic method |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003200441B2 (en) * | 1998-04-29 | 2006-07-06 | Allergan, Inc. | Compositions and methods for modulating neural sprouting |
| GB9914861D0 (en) * | 1999-06-25 | 1999-08-25 | Imperial College | Tetanus toxin polypeptides |
| WO2002000172A2 (en) * | 2000-06-28 | 2002-01-03 | Ira Sanders | Methods for using tetanus toxin for benificial purposes in animals (mammals) |
| US20020197278A1 (en) * | 2001-06-21 | 2002-12-26 | Surromed, Inc. | Covalent coupling of botulinum toxin with polyethylene glycol |
| AU2003237346A1 (en) * | 2002-05-31 | 2003-12-19 | Thomas Jefferson University | Compositions and methods for transepithelial molecular transport |
| WO2008024879A1 (en) * | 2006-08-25 | 2008-02-28 | University Of Maryland, Baltimore | Use of tetanus toxin to amplify inadequate voluntary muscle contraction or to improve muscle tone in an animal actively vaccinated against the toxin and a regimen for treatment |
| KR101818777B1 (ko) * | 2009-04-27 | 2018-01-15 | 메르츠 파마 게엠베하 운트 코. 카가아 | 신경독 폴리펩티드의 양 및 이들의 촉매 활성 및 단백질 분해 활성의 결정수단 및 방법 |
| ES2616258T3 (es) * | 2010-03-15 | 2017-06-12 | Academisch Ziekenhuis Leiden H.O.D.N. Lumc | Péptidos, conjugados y métodos para aumentar la inmunogenicidad de una vacuna |
| US20170151316A1 (en) * | 2014-07-02 | 2017-06-01 | Spherium Biomed, S.L. | Methods of increasing muscle mass using non-toxic tetanus toxin c fragment (ttc) |
| US10704035B2 (en) * | 2015-08-27 | 2020-07-07 | President And Fellows Of Harvard College | Compositions and methods for treatment of pain |
| CN106692963B (zh) * | 2016-12-28 | 2020-12-22 | 中国人民解放军军事医学科学院生物工程研究所 | 一种用于预防金黄色葡萄球菌感染和破伤风的联合疫苗 |
| EP3723784A4 (en) * | 2017-12-15 | 2022-01-12 | The Medical College of Wisconsin, Inc. | USE OF MODIFIED CLOSTRIDIAL NEUROTOXINS AS VACCINES AND CONJUGATE VACCINE PLATFORMS |
| WO2021155427A1 (en) * | 2020-02-03 | 2021-08-12 | Snoretox Pty Ltd | Composition and method |
-
2019
- 2019-07-30 AU AU2019315327A patent/AU2019315327B2/en active Active
- 2019-07-30 EP EP22183027.6A patent/EP4134133A1/en active Pending
- 2019-07-30 EP EP19843147.0A patent/EP3830110A4/en active Pending
- 2019-07-30 MX MX2021001181A patent/MX2021001181A/es unknown
- 2019-07-30 SG SG11202100646SA patent/SG11202100646SA/en unknown
- 2019-07-30 KR KR1020217006098A patent/KR20210040407A/ko not_active Ceased
- 2019-07-30 JP JP2021529491A patent/JP2021533201A/ja active Pending
- 2019-07-30 BR BR112021001520-5A patent/BR112021001520A2/pt unknown
- 2019-07-30 CA CA3167665A patent/CA3167665A1/en active Pending
- 2019-07-30 NZ NZ772266A patent/NZ772266A/en unknown
- 2019-07-30 CA CA3108079A patent/CA3108079C/en active Active
- 2019-07-30 CN CN202510841942.0A patent/CN120661638A/zh active Pending
- 2019-07-30 US US17/261,975 patent/US20210353724A1/en active Pending
- 2019-07-30 CN CN201980057158.3A patent/CN112638937B/zh active Active
- 2019-07-30 WO PCT/AU2019/050793 patent/WO2020024002A1/en not_active Ceased
-
2023
- 2023-11-20 JP JP2023196375A patent/JP7786745B2/ja active Active
-
2025
- 2025-11-25 JP JP2025203043A patent/JP2026026159A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2277505A3 (en) | Mucoactive agents for treating a pulmonary disease | |
| US20230348536A1 (en) | Conjugates of montelukast and peptides | |
| CN109640953B (zh) | 包含带有羧酸根电荷和疏水性基团的共聚氨基酸的可注射溶液 | |
| JP4249802B2 (ja) | 神経筋疾患および症状を処置するためのボツリヌス毒素組み合わせ | |
| JP2002087987A (ja) | ジストニーを処置するためのｃ型〜ｇ型ボツリヌス毒素含有医薬組成物 | |
| JP2003507438A5 (https=) | ||
| RU2005135016A (ru) | Производные хинолина в качестве ингибиторов фосфодиэстеразы | |
| WO2006059108A3 (en) | ANTI-IL-IRl SINGLE DOMAIN ANTIBODIES AND THERAPEUTIC USES | |
| WO2013039187A1 (ja) | グアニジノ安息香酸化合物 | |
| JP2008528549A (ja) | 構造的に充分に定義された分岐ポリマーと接合されたインスリン誘導体 | |
| JP2026000993A (ja) | 新ペプチド | |
| US20230331792A1 (en) | New multi-functional oligopeptides | |
| JP2026506026A (ja) | 新規多機能オリゴペプチド | |
| CA3211907A1 (en) | New peptide conjugates | |
| US20240218016A1 (en) | Peptides and their use in the treatment of inflammation | |
| JPWO2020024002A5 (https=) | ||
| US20060252685A1 (en) | Treatment for sleep apnea | |
| JP2021533201A5 (https=) | ||
| US20220105082A1 (en) | New formulations containing leukotriene receptor antagonists | |
| JPWO2020255574A5 (https=) | ||
| JP2026067913A (ja) | 新規なペプチドと多糖類とのコンジュゲート | |
| US20210087232A1 (en) | D-enantiomeric peptides for anti-inflammatory treatment of amyotropic lateral sclerosis (als) and other diseases driven by neuro-inflammation | |
| RU2008105972A (ru) | Новая соль i | |
| Onoue et al. | Inhaled Biologics: Overcoming Challenges and Recent Advances | |
| HK40005659B (zh) | 包含带有羧酸根电荷和疏水性基团的共聚氨基酸的可注射溶液 |